MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 16.94
+0.05 (0.30%)
Sep 5, 2025, 5:36 PM CET
MedinCell Market Cap
MedinCell has a market cap or net worth of €560.58 million as of September 5, 2025. Its market cap has increased by 5.31% in one year.
Market Cap
560.58M
Enterprise Value
556.01M
Revenue
27.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
€16.94
Market Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 560.58M, an increase of 283.68%. That is a compound annual growth rate of 21.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 560.58M | 15.40% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | 225.98M | 63.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 119.99B |
| Sanofi | 96.29B |
| Sartorius Stedim Biotech | 16.63B |
| bioMérieux | 13.64B |
| Eurofins Scientific SE | 11.15B |
| Ipsen | 9.88B |
| ABIVAX Société Anonyme | 5.50B |
| Virbac | 2.73B |